A vaccine targeting gonorrhea will soon be rolled out on the NHS. This will make England and Wales the first two countries in ...

Research has shown that the 4CMenB vaccine provides some protection against an infection from the Neisseria gonorrhoeae ...

The World Health Organization (WHO) today posted an outbreak notice about a rise in COVID activity in three of its regions, ...

Debiopharm initially received funding from CARB-X in 2017 for pre-clinical development of Debio1453, which inhibits an ...

Debiopharm ( a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standard-of-care to cure ...

Research conducted by the Joint Committee on Vaccination and Immunisation (JCVI) indicates that the new vaccine is 32.7% to ...

A world-first vaccine for gonorrhoea is being rolled out in England after the number of cases hit record highs. The number of ...

A vaccine for gonorrhoea will be rolled out in England as part of a world-first programme, officials have announced.

Thousands of gonorrhoea cases could be prevented over the next decade thanks to the NHS’ world-first vaccination programme against the infection. Eligible patients, which includes gay and bisexual men ...

A new vaccine for gonorrhoea is to be rolled out by the NHS in England to tackle a rise in antibiotic-resistant “super” ...

Treatment with retifanlimab plus carboplatin-paclitaxel statistically significantly reduced the risk of progression or death by 37% compared with placebo plus carboplatin-paclitaxel. The Food and ...

The FDA granted Efti fast track designation for first-line treatment of head and neck squamous cell carcinoma and non–small cell lung cancer. First-line treatment with a Keytruda combo had an overall ...